The purebreds in this horse race are narrowing down to 70 products, on the back of MSB then came Pluristem jumped 28% they qualify for Euro53M for R&D, then Athersys up 21%, Moderna news of R&D grant US$483M small jump, even Gilead a few % on further defence of their trial problems. MSB is certainly worth a ride for this Monday for the 120% jump
DYOR
Stupid Halts killed momo, page-28
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.040(3.16%) |
Mkt cap ! $1.490B | |||
| Open | High | Low | Value | Volume |
| $1.28 | $1.32 | $1.26 | $3.433M | 2.652M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39558 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 21776 | 3 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |